Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 13 | 2021 | 707 | 1.890 |
Why?
|
| Cognitive Dysfunction | 7 | 2022 | 449 | 1.580 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 464 | 1.400 |
Why?
|
| Gait | 2 | 2019 | 195 | 0.990 |
Why?
|
| Aging | 6 | 2020 | 680 | 0.980 |
Why?
|
| Exercise | 4 | 2021 | 233 | 0.960 |
Why?
|
| Cognition | 7 | 2022 | 641 | 0.780 |
Why?
|
| Postmortem Changes | 2 | 2016 | 17 | 0.770 |
Why?
|
| Neuropathology | 2 | 2020 | 42 | 0.740 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 2152 | 0.720 |
Why?
|
| Independent Living | 4 | 2020 | 137 | 0.700 |
Why?
|
| Postural Balance | 2 | 2021 | 62 | 0.680 |
Why?
|
| Hippocampus | 3 | 2020 | 97 | 0.640 |
Why?
|
| Female | 19 | 2021 | 6974 | 0.580 |
Why?
|
| White Matter | 2 | 2018 | 52 | 0.580 |
Why?
|
| Male | 18 | 2021 | 6815 | 0.580 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 29 | 0.540 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 278 | 0.530 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 57 | 0.530 |
Why?
|
| Humans | 25 | 2022 | 12240 | 0.520 |
Why?
|
| Motor Activity | 1 | 2018 | 175 | 0.490 |
Why?
|
| Knee Joint | 1 | 2019 | 284 | 0.490 |
Why?
|
| Aged | 14 | 2022 | 4000 | 0.450 |
Why?
|
| Alzheimer Disease | 7 | 2021 | 800 | 0.420 |
Why?
|
| Autopsy | 6 | 2021 | 174 | 0.420 |
Why?
|
| Wearable Electronic Devices | 2 | 2021 | 21 | 0.310 |
Why?
|
| Formaldehyde | 1 | 2009 | 5 | 0.290 |
Why?
|
| Accelerometry | 2 | 2019 | 48 | 0.280 |
Why?
|
| Parkinsonian Disorders | 2 | 2020 | 91 | 0.280 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 651 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 81 | 0.280 |
Why?
|
| Cohort Studies | 6 | 2020 | 827 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 38 | 0.210 |
Why?
|
| Neuroimaging | 2 | 2021 | 66 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 93 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 6 | 0.170 |
Why?
|
| Motor Skills | 1 | 2021 | 32 | 0.170 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 6 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 97 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 60 | 0.160 |
Why?
|
| Tremor | 1 | 2021 | 60 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 67 | 0.160 |
Why?
|
| Temporal Lobe | 1 | 2020 | 29 | 0.150 |
Why?
|
| Parkinson Disease | 2 | 2021 | 314 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 5 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 558 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 45 | 0.150 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 50 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 20 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 32 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 46 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2019 | 105 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 190 | 0.140 |
Why?
|
| Bone Resorption | 1 | 2019 | 55 | 0.140 |
Why?
|
| Organ Size | 2 | 2015 | 41 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 5 | 0.140 |
Why?
|
| Thalamus | 1 | 2018 | 7 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 26 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 96 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 36 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 157 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 15 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 18 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2017 | 17 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Joint Instability | 1 | 2019 | 145 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 69 | 0.120 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 10 | 0.120 |
Why?
|
| Plasmacytoma | 1 | 2016 | 6 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 87 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2017 | 437 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 20 | 0.120 |
Why?
|
| Shoulder Joint | 1 | 2019 | 228 | 0.120 |
Why?
|
| Gray Matter | 1 | 2016 | 11 | 0.120 |
Why?
|
| Neocortex | 1 | 2016 | 17 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 15 | 0.120 |
Why?
|
| Algorithms | 1 | 2013 | 169 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 19 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 36 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2010 | 59 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 4 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 4043 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 281 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 96 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 151 | 0.060 |
Why?
|
| Memory | 2 | 2017 | 112 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 324 | 0.060 |
Why?
|
| Depression | 2 | 2017 | 229 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 47 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 31 | 0.050 |
Why?
|
| Walking | 1 | 2022 | 108 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 161 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 22 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 6 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 423 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 102 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 290 | 0.040 |
Why?
|
| Software | 1 | 2019 | 26 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 338 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 49 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2019 | 68 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 453 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 363 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 17 | 0.030 |
Why?
|
| Sclerosis | 1 | 2017 | 32 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 23 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 73 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 3557 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 17 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 18 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 43 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 119 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 108 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 110 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 169 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 1049 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2017 | 40 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 41 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 66 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 117 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 155 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 1467 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 25 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 117 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 166 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 252 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 863 | 0.020 |
Why?
|